Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): Results from two phase 3 randomised trials

Christopher E.M. Griffiths*, Kristian Reich, Mark Lebwohl, Peter Van De Kerkhof, Carle Paul, Alan Menter, Gregory S. Cameron, Janelle Erickson, Lu Zhang, Roberta J. Secrest, Susan Ball, Daniel K. Braun, Olawale O. Osuntokun, Michael P. Heffernan, Brian J. Nickoloff, Kim Papp, Diamant Thaci

*Korrespondierende/r Autor/-in für diese Arbeit
280 Zitate (Scopus)

Fingerprint

Untersuchen Sie die Forschungsthemen von „Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): Results from two phase 3 randomised trials“. Zusammen bilden sie einen einzigartigen Fingerprint.

Medizin & Biologie